Vivozon Pharmaceutical Co., Ltd.

Vivozon Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company actively engaged in the research, development, and commercialization of novel pharmaceuticals, particularly in the realm of pain management. Focused primarily on overcoming the challenges associated with opioid-based therapies, Vivozon aims to innovate non-opioid alternatives to treat chronic and acute pain effectively. The company leverages its proprietary technologies and a robust pipeline of drug candidates to address global pain relief needs, making it a pivotal player in the pharmaceutical industry dedicated to neurological health. With a commitment to innovation and safety, Vivozon's developments are crucial amid the rising demand for safer pain management solutions, thus playing an instrumental role in transforming therapeutic approaches and enhancing patient care outcomes across diverse healthcare markets worldwide.